These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1805727)

  • 1. A comparison of the thrombogenic activity of prothrombin complex concentrates using stasis and non-stasis models.
    Richter M; Klöcking HP; Dornheim G; Güttner J; Wulkow R
    Arch Toxicol Suppl; 1991; 14():170-3. PubMed ID: 1805727
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
    Prowse CV; Williams AE
    Thromb Haemost; 1980 Oct; 44(2):81-6. PubMed ID: 6779401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates and coagulation.
    Penner JA
    Ann Intern Med; 1976 Oct; 85(4):531-2. PubMed ID: 970783
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombogenic materials in prothrombin complex concentrates.
    Blatt PM; Lundblad RL; Kingdon HS; McLean G; Roberts HR
    Ann Intern Med; 1974 Dec; 81(6):766-70. PubMed ID: 4433081
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of thrombogenicity of prothrombin complex concentrates in a porcine model.
    Harrison J; Abildgaard C; Lazerson J; Culbertson R; Anderson G
    Thromb Res; 1985 Apr; 38(2):173-88. PubMed ID: 4002204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and composition of prothrombin complex concentrates: correlation between composition and therapeutic efficiency.
    Hellstern P
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S7-12. PubMed ID: 10499903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenicity of prothrombin complex concentrates.
    Köhler M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S13-7. PubMed ID: 10499904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravascular coagulation with use of human prothrombin complex concentrates.
    Cederbaum AI; Blatt PM; Roberts HR
    Ann Intern Med; 1976 Jun; 84(6):683-7. PubMed ID: 937880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.
    Silberman S; Fareed J; Walenga J
    Br J Exp Pathol; 1986 Aug; 67(4):597-604. PubMed ID: 3091059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial to produce disseminated intravascular coagulation with intravenous infusion of homologous haemolysate and serum in cats.
    Bengmark S; Hafström L; Korsan-Bengtsen K
    Acta Chir Scand; 1972; 138(5):453-7. PubMed ID: 5055978
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo models of thrombogenic potential: usefulness and limitations.
    MacGregor I; McLaughlin L; Drummond O; Prowse C; Ferguson J
    Acta Haematol; 1995; 94 Suppl 1():18-23; discussion 24. PubMed ID: 7571990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatostatin and the hemostatic system (author's transl)].
    Hnidec O
    Przegl Lek; 1980; 37(4):421-3. PubMed ID: 6105700
    [No Abstract]   [Full Text] [Related]  

  • 15. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties.
    Abid Hussein MN; Böing AN; Biró E; Hoek FJ; Vogel GM; Meuleman DG; Sturk A; Nieuwland R
    Thromb Res; 2008; 121(6):865-71. PubMed ID: 17889282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombogenicity of a factor IX concentrate quantitated in a canine model.
    MacGregor IR; Ferguson JF; Dawes J; McLaughlin L; Prowse CV
    Blood Coagul Fibrinolysis; 1990; 1(1):23-30. PubMed ID: 2102787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drugs on disseminated intravascular coagulation (DIC). V. Effects of alpha-adrenoceptor blocking agents on thrombin-induced DIC in rats.
    Nowak G; Markwardt F
    Thromb Res; 1981 May; 22(4):417-25. PubMed ID: 6117138
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated intravascular coagulation caused by moojenactivase, a procoagulant snake venom metalloprotease.
    Sartim MA; Cezarette GN; Jacob-Ferreira AL; Frantz FG; Faccioli LH; Sampaio SV
    Int J Biol Macromol; 2017 Oct; 103():1077-1086. PubMed ID: 28552727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of inhibitors on the thrombogenicity and toxicity of prothrombin complex concentrates.
    Klöcking HP; Dornheim G; Schulze-Riewald H
    Arch Toxicol Suppl; 1987; 11():313-5. PubMed ID: 2443111
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombogenicity associated with factor IX complex concentrates.
    Lusher JM
    Semin Hematol; 1991 Jul; 28(3 Suppl 6):3-5. PubMed ID: 1780767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.